Segal Saya, John Gabriella, Sammel Mary, Andy Uduak Umoh, Chu Christina, Arya Lily A, Brown Justin, Schmitz Kathryn
Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, and Division of Urology, Department of Surgery, Rutgers - Robert Wood Johnson Medical School, New Brunswick, NJ, United States.
Memorial Sloan-Kettering Cancer Center, New York, NY, United States.
Maturitas. 2017 Nov;105:83-88. doi: 10.1016/j.maturitas.2017.03.313. Epub 2017 Mar 18.
To investigate radiation therapy as a risk factor for urinary or fecal incontinence, pelvic organ prolapse, and sexual dysfunction in endometrial cancer survivors.
We performed a retrospective cohort study of endometrial cancer survivors. Data were collected using a mailed survey and the medical record. Validated questionnaires were used to generate rates of urinary incontinence and other pelvic floor disorders. The incidence rates of pelvic floor disorders were compared across groups with different exposures to radiation.
Of the 149 endometrial cancer survivors, 41% received radiation therapy. Fifty-one percent of women reported urine leakage. The rates of urinary incontinence in women exposed and not exposed to vaginal brachytherapy (VBT) or whole-pelvis radiation were 48% and 58%, respectively (p=0.47). The incidence of fecal incontinence did not differ between groups, but the score for overall sexual function was significantly higher in women who did not undergo radiation therapy. On multivariable analysis, significant risk factors for urinary incontinence were age (AOR 1.06 95% CI 1.02, 1.10) and BMI (AOR 1.07 95% CI 1.02, 1.11), but treatment with radiation was not significantly associated with urinary incontinence, or fecal incontinence (p>0.05). Age, BMI, and radiation exposure were independent predictors of decreased sexual function score (p<0.01).
Local or regional radiation is not associated with urinary or fecal incontinence, but may contribute to sexual dysfunction in endometrial cancer survivors.
探讨放射治疗作为子宫内膜癌幸存者尿失禁或大便失禁、盆腔器官脱垂及性功能障碍的危险因素。
我们对子宫内膜癌幸存者进行了一项回顾性队列研究。通过邮寄调查问卷和查阅病历收集数据。使用经过验证的问卷来计算尿失禁及其他盆底疾病的发生率。比较不同放射暴露组的盆底疾病发病率。
149名子宫内膜癌幸存者中,41%接受了放射治疗。51%的女性报告有尿液渗漏。接受和未接受阴道近距离放疗(VBT)或全盆腔放疗的女性尿失禁发生率分别为48%和58%(p = 0.47)。各组间大便失禁的发生率无差异,但未接受放射治疗的女性总体性功能评分显著更高。多变量分析显示,尿失禁的显著危险因素为年龄(比值比[AOR]1.06,95%置信区间[CI]1.02,1.10)和体重指数(BMI)(AOR 1.07,95%CI 1.02,1.11),但放射治疗与尿失禁或大便失禁无显著相关性(p>0.05)。年龄、BMI和放射暴露是性功能评分降低的独立预测因素(p<0.01)。
局部或区域放射与尿失禁或大便失禁无关,但可能导致子宫内膜癌幸存者出现性功能障碍。